Although there is no clearly defined morphologic and immunoreactivity criteria of SFT and the four described SFTs of the cervix differ somewhat in the immunoprofile (Table 1), immunohistochemical detection of CD34 and bcl-2 was helpful in our preoperational diagnosis of the large biopsy specimen, since the two markers were suggested to differentiate SFT from other spindle-cell tumours [3]. The gene discussed is BCL2; the disease is spindle cell neoplasm.